Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus; tacrolimus monohydrate - hart forðahylki - 2 mg

Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 3 mg

Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - venlafaxinum hýdróklóríð - hart forðahylki - 150 mg

Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - venlafaxinum hýdróklóríð - hart forðahylki - 75 mg

Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

mcneil sweden ab - simeticonum inn - mjúkt hylki - 240 mg

Europska Unija - islandski - EMA (European Medicines Agency)

nova laboratories ireland limited - spironolactone - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 5.

Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

laboratorios hipra s.a. - escherichia coli, fimbrial adhesin f4ab; escherichia coli, fimbrial adhesin f4ac; escherichia coli, fimbrial adhesin f5; escherichia coli, fimbrial adhesin f6; escherichia coli, purified lt toxin; clostridium perfringens type-c beta toxoid; clostridium novyi, type b, alpha toxoid - stungulyf, dreifa